Form 4: Ceribell CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Ceribell Inc.'s President and CEO, Chao Xingjuan, exercised options and immediately sold 25,000 shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- Chao Xingjuan, President and CEO of Ceribell, Inc., reported transactions on December 1, 2025.
- Exercised options to acquire 25,000 shares of common stock at an exercise price of $3.65 per share.
- Simultaneously sold 25,000 shares of common stock at a weighted average price of $16.59 per share, with individual sales ranging from $16.38 to $16.82.
- These transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale.
- Following these transactions, Chao Xingjuan directly owns 798,135 shares of common stock and indirectly owns 369,088 shares through the ACP 2021 Trust.
- Chao Xingjuan also holds 232,100 stock options with an exercise price of $3.65, which vest monthly from June 10, 2021, and expire on June 10, 2031.
Sentiment
Score: 6
Explanation: The transactions represent a pre-planned exercise of options and sale of shares by a key executive, indicating a personal financial event rather than a change in company outlook. The profitable nature of the exercise is positive for the executive, and the 10b5-1 plan mitigates concerns about opportunistic selling, leading to a neutral to slightly positive sentiment.
Positives
- The Reporting Person realized a significant gain by selling shares at a weighted average price of $16.59 after exercising options at $3.65.
- The transactions were executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than an immediate reaction to market conditions, which can mitigate concerns about opportunistic insider selling.
Negatives
- The President and CEO sold a notable number of shares, which could be interpreted by some investors as a lack of confidence, despite being part of a 10b5-1 plan.
Risks
- NA
Future Outlook
NA
Industry Context
NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA
Related Party Transactions
- Indirect beneficial ownership of 369,088 common shares through the ACP 2021 Trust, where the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
Stakeholder Impact
- Shareholders may interpret the insider sale differently; some may view it as a negative signal, while others will recognize it as a planned liquidity event under a 10b5-1 plan.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2021-06-10 | Start date for monthly vesting of stock options. |
| 2025-12-01 | Date of option exercise and common stock sale transactions. |
| 2025-12-03 | Date Form 4 was signed. |
| 2031-06-10 | Expiration date of stock options. |
Recommendation
holdThe Form 4 filing details a pre-planned insider transaction (exercise of options and subsequent sale of shares) by the President and CEO. While insider selling can sometimes be a concern, the execution under a Rule 10b5-1 plan suggests a scheduled liquidity event rather than a reaction to new negative information. The significant profit realized by the executive from the option exercise is a positive for the individual but does not inherently change the investment thesis for the company. Without additional information on company performance or strategic direction, the filing alone does not warrant a change from a 'hold' position.
Keywords
Ceribell, CBLL, Form 4, insider trading, stock options, share sale, CEO, 10b5-1 plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.